Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cureus
|
February 24, 2025
Drug-Induced Chylothorax During Chemotherapy With Ramucirumab and Paclitaxel for Advanced Gastric Cancer
Kenichi Sawa, Kohei Hayashi, Yuki Sonoda, et al.
Internal Medicine (Tokyo, Japan)
|
August 28, 2018
Rectal Paraganglioma
Tomonori Araki, Shigeyuki Takeshita, Hiroko Kawasaki, et al.
DEN Open
|
July 20, 2023
Dabigatran-induced esophagitis with full circumferential blue pigmentation
Tomonori Araki, Kohei Hayashi, Yuki Sonoda, et al.
Cancers
|
September 9, 2022
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles
Tomonori Araki, Kensuke Hamada, Aung Bhone Myat, et al.
General Thoracic and Cardiovascular Surgery Cases
|
November 9, 2024
Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report
Takahiro Enjoji, Shinichiro Kobayashi, Kohei Hayashi, et al.
Anti-Cancer Drugs
|
June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract
Tomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Cancers
|
April 30, 2020
Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under <i>Parg</i> Deficiency
Yuki Sonoda, Yuka Sasaki, Akemi Gunji, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
International Journal of Cancer
|
August 1, 2025
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid
Tomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Scientific Reports
|
January 27, 2025
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)
Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cureus
|
February 24, 2025
Drug-Induced Chylothorax During Chemotherapy With Ramucirumab and Paclitaxel for Advanced Gastric Cancer
Kenichi Sawa, Kohei Hayashi, Yuki Sonoda, et al.
Internal Medicine (Tokyo, Japan)
|
August 28, 2018
Rectal Paraganglioma
Tomonori Araki, Shigeyuki Takeshita, Hiroko Kawasaki, et al.
DEN Open
|
July 20, 2023
Dabigatran-induced esophagitis with full circumferential blue pigmentation
Tomonori Araki, Kohei Hayashi, Yuki Sonoda, et al.
Cancers
|
September 9, 2022
Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles
Tomonori Araki, Kensuke Hamada, Aung Bhone Myat, et al.
General Thoracic and Cardiovascular Surgery Cases
|
November 9, 2024
Long-term survival after conversion surgery for an esophageal neuroendocrine carcinoma: a case report
Takahiro Enjoji, Shinichiro Kobayashi, Kohei Hayashi, et al.
Anti-Cancer Drugs
|
June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract
Tomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Cancers
|
April 30, 2020
Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under <i>Parg</i> Deficiency
Yuki Sonoda, Yuka Sasaki, Akemi Gunji, et al.
Therapeutic Advances in Medical Oncology
|
February 24, 2025
Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
Tomonori Araki, Kohei Hayashi, Mototsugu Shimokawa, et al.
International Journal of Cancer
|
August 1, 2025
Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid
Tomonori Araki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, et al.
Scientific Reports
|
January 27, 2025
Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)
Tomonori Araki, Yuki Sonoda, Mototsugu Shimokawa, et al.
Page
of 2